Tanya B. Dorff

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial”.

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02568-1

N/A

5.2DataRank · unranked

135 citations

Siamak Daneshmand, Sudeh Izadmehr, Edgar Gonzalez‐Kozlova, Kevin Chan, Sara Lewis +35 more

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Nature Medicine(2024)10.1038/s41591-024-02979-8

N/A

1.8DataRank · unranked

124 citations

M. Suzette Blanchard, Lauren Adkins, Laura Luebbert, Neena A. Leggett, Stephanie N. Shishido +23 more

Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk

Nature Communications(2024)10.1038/s41467-024-45260-9

N/A

1.2DataRank · unranked

59 citations

Morgan E. Levine, Min Wei, Mahshid Shelehchi, Todd E. Morgan, Krishna S. Nayak +6 more

Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity

Molecular Therapy(2021)10.1016/j.ymthe.2021.02.024

N/A

0.700DataRank · unranked

105 citations

Dileshni Tilakawardane, Anthony K. Park, Lupita S. Lopez, Cari A. Young, Jackson Gibson +13 more

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial

Integrative Cancer Therapies(2021)10.1177/15347354211035442

N/A

0.522DataRank · unranked

10 citations

Tanya B. Dorff, Creighton T. Tuzon, Judd C. Rice, E. Todd Schroeder, Christianne J. Lane +3 more

Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment

Clinical and Translational Medicine(2024)10.1002/ctm2.70048

N/A

0.457DataRank · unranked

12 citations

Shoubao Ma, Przemyslaw Twardowski, Clayton Lau, Yin Chan, Kelly Wong +12 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0.457DataRank · unranked

8 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy

The Oncologist(2023)10.1093/oncolo/oyad036

N/A

0.434DataRank · unranked

17 citations

Oren Wei, Ni‐Chun Tsai, Joycelynne Palmer, Sumanta K. Pal, Yung Lyou +2 more

Cancer transcriptomic profiling from rapidly enriched circulating tumor cells

International Journal of Cancer(2020)10.1002/ijc.32915

N/A

0.385DataRank · unranked

12 citations

Alexander Cunha, Nita Jojo, Yucheng Xu, Yili Xu, Eric S. C. Kwok +7 more

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

European Urology Oncology(2024)10.1016/j.euo.2024.03.001

N/A

0.345DataRank · unranked

9 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo +17 more

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients

Translational Andrology and Urology(2021)10.21037/tau-20-1053

N/A

0.330DataRank · unranked

8 citations

Tanya B. Dorff, Yung Lyou

Phase II trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.94

N/A

0.208DataRank · unranked

3 citations

David B. Agus, Tanya B. Dorff, Jacek Pinski, David I. Quinn, Olga Castellanos +3 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0.208DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5074

N/A

0.165DataRank · unranked

2 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Yeonjung Jo, Andrea Harzstark +15 more

Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5080

N/A

0.165DataRank · unranked

2 citations

Catherine M. Tangen, Melissa Plets, Daniel Bsteh, Tong Xu, Jacek Pinski +13 more

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Cancer(2024)10.1002/cncr.35560

N/A

0.165DataRank · unranked

2 citations

Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun +11 more

Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216

European Urology Oncology(2024)10.1016/j.euo.2024.10.013

N/A

0.165DataRank · unranked

2 citations

Yeonjung Jo, Arshit Narang, Melissa Plets, Chadi Hage Chehade, Georges Gebrael +10 more

PD-L1 blockade restores CAR T cell activity through IFNγ-regulation of CD163+ macrophages

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.25.477150

N/A

0.104DataRank · unranked

1 citations

Jackson Gibson, Kevin Ou, Raymond T. Ng, Neena A. Leggett, Vanessa D. Jönsson +8 more

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Thyroid(2024)10.1089/thy.2023.0542

N/A

0DataRank · unranked

17 citations

Huiyan Ma, Tom Z. Liang, Yan Xing, Samuel Chung, Tanya B. Dorff +3 more

Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review

Cancers(2022)10.3390/cancers14205149

N/A

0DataRank · unranked

44 citations

Eemon Tizpa, Errol J. Philip, Qianhua Feng, Ziyi Huang, Reeny M. Thomas +4 more

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004400

N/A

0DataRank · unranked

120 citations

Jackson Gibson, Kevin Ou, Lupita S. Lopez, Raymond T. Ng, Neena A. Leggett +9 more

The Role of Diverse Populations in US Clinical Trials

Med(2021)10.1016/j.medj.2020.12.009

N/A

0DataRank · unranked

34 citations

Jabril R. Johnson, Stanley Hooker, Fornati Bedell, Tanya B. Dorff, Rick A. Kittles +1 more

Pre-conditioning Modifies the Tumor Microenvironment to Enhance Solid Tumor CAR T Cell Efficacy and Endogenous Immunity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.18.388892

N/A

0DataRank · unranked

3 citations

Dileshni Tilakawardane, Anthony K. Park, Kelly T. Kennewick, Lupita S. Lopez, Hee Jun Lee +10 more

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer

Cancers(2025)10.3390/cancers17101730

N/A

0DataRank · unranked

0 citations

Diane M. Da Silva, Zhang‐Xu Liu, Shivani Kandukuri, Denice Tsao‐Wei, Anishka D'souza +8 more

Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations

European Urology Focus(2025)10.1016/j.euf.2025.11.011

N/A

0DataRank · unranked

0 citations

Sam Callis, Evan Y. Yu, Scott E. Delacroix, Alexandra Sokolova, Catherine M. Tangen +4 more

Geriatric Assessment-driven INterventions among Hospitalized older adults with cancer (GAIN-HOSP), a prospective pilot study

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.102063

N/A

0DataRank · unranked

0 citations

Can‐Lan Sun, Heeyoung Kim, Carolina Uranga, Enrique Soto‐Pérez‐de‐Celis, Peggy Burhenn +14 more

Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e17111

N/A

0DataRank · unranked

1 citations

Jonathan D. Buckley, Scott A. Mitchell, Dejerianne Ostrow, Jean‐Hugues Parmentier, Samin Maleki Jahan +13 more

HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5036

N/A

0DataRank · unranked

0 citations

Jonathan D. Buckley, Dejerianne Ostrow, Jean‐Hugues Parmentier, Smruthi Maganti, Scott A. Mitchell +14 more

DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.129

N/A

0DataRank · unranked

0 citations

Richard E. Green, Joseph J. Park, Olesia Kellezi, Clara Hwang, Pedro C. Barata +15 more